Mood Swings

R&B SINGER-SONGWRITER VEDO SIGNS WITH CAA

Retrieved on: 
Friday, March 10, 2023
MI, City, Singer-songwriter, Multimedia, ABC, NY, DC, R, EP, IL, Album, NC, The Voice (American season 4), House, Creative Artists Agency, The Voice, Don't Waste My Time, Human voice, Breezy (album), Roxy, R&B, HOB, MA, PA, Mood Swings, LA, You Got It, CAA, Music, Nightclub

LOS ANGELES, March 10, 2023 /PRNewswire/ -- Following the recent release of his 6th Studio Album, Mood Swings, VEDO has just announced the details of his highly anticipated tour set to kick off May 4th, 2023. The announcement comes at the brink of his signing with Creative Artist Agency (CAA), the leading entertainment conglomerate who represent a plethora of talent across all genres and industries.

Key Points: 
  • LOS ANGELES, March 10, 2023 /PRNewswire/ -- Following the recent release of his 6th Studio Album, Mood Swings, VEDO has just announced the details of his highly anticipated tour set to kick off May 4th, 2023.
  • The announcement comes at the brink of his signing with Creative Artist Agency (CAA), the leading entertainment conglomerate who represent a plethora of talent across all genres and industries.
  • Tickets will be available to purchase nationwide today at 10am PST.
  • The release of Mood Swings coincides with an impressive wave of momentum from the R&B artist as he remains consistent in delivering new age R&B hits with a nostalgic feel.

Women's Health Brand O Positiv Expands Into The Menopause Category With The First-Ever Menopause Gummy Vitamin

Retrieved on: 
Wednesday, January 18, 2023
Flash, URO, Immunity, OBGYN, Gummy candy, Menopause, Capsule, PMS, LOS, Mood Swings, Product innovation, Vitex agnus-castus, Woman, FLO, Taboo, Patient, Academic Model Providing Access to Healthcare (AMPATH), Vitamin B6, Actaea racemosa, Vitamin, Progesterone, Personal lubricant, UTI, Birth control, Dietary supplement, Withania somnifera

LOS ANGELES, Jan. 18, 2023 /PRNewswire/ -- Following the creation of their hero product, FLO Vitamins, and the recent success of their MENO Capsule launch, O Positiv is continuing to target menopause-aged women head on with its latest product launch today, MENO Gummies. The all-natural, hormone-free gummies are formulated with the same research-backed ingredients as the brand's MENO capsules, all of which have been shown to help alleviate common menopause-related symptoms.

Key Points: 
  • Since the launch of their MENO Capsules back in May, the demand for more menopause support has grown significantly, incentivizing the brand to create the formula in gummy format.
  • Watching the Bitton sibling's mother, Mary Kay Bitton, suffer from a debilitating menopause experience further pushed them to expedite the process of creating this much-needed product.
  • For my patients that are seeking natural solutions to symptoms like hot flashes and night sweats, I recommend taking MENO."
  • O Positiv was the first brand to take on PMS with its flavorful, science-backed gummy supplement FLO , which allowed the company to expand its horizon to address equally common women's health issues.

Gameto Expands Executive Team with the Appointment of David McCulloh, Ph.D., H.C.L.D., C.C. as Vice President of Embryology

Retrieved on: 
Tuesday, January 10, 2023
Work, Gynaecology, IVF, Obstetrics, Pain, Egg, Fertility, Medical school, Research, Cell engineering, Sport, Mood Swings, Reproductive medicine, McCulloh, Department of Obstetrics and Gynecology (Massachusetts General Hospital), New York University Grossman School of Medicine, Constipation, ART, Reproduction, University of Miami Division of Surgical Neurooncology, Nausea, Hospital, Oregon Health & Science University, Faculty, Weight gain, Bloating, RMA, University, Therapy, Laboratory, New Jersey Medical School, Lab, Human, School, NYU, Woman, Oocyte, Pharmaceutical industry, Birth control, Embryology

NEW YORK, Jan. 10, 2023 /PRNewswire/ -- Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, today announced the appointment of David McCulloh, Ph.D., H.C.L.D., C.C. as Vice President of Embryology.

Key Points: 
  • NEW YORK, Jan. 10, 2023 /PRNewswire/ -- Gameto, a biotechnology company using cell engineering to develop therapeutics for diseases of the female reproductive system, today announced the appointment of David McCulloh, Ph.D., H.C.L.D., C.C.
  • as Vice President of Embryology.
  • "We are thrilled to have David join our team in New York," said Dina Radenkovic, co-founder and CEO of Gameto.
  • "Gameto's focus on developing a therapeutic that makes IVF and egg freezing shorter, safer, and more effective captivated my attention.

IEHP team helps break mental health stigma, one new mom at a time

Retrieved on: 
Tuesday, December 27, 2022
Anxiety, Depression, United States Public Health Service, Health, Community, Cal, CDC, Medicare, Mental health, Mood Swings, Multimedia, Psychiatry, Pregnancy, Woman, Happiness, Medicine, Katia, Medicaid

After the birth of her daughter, Gerti struggled with her mental health and recognized she needed help – so she turned to IEHP.

Key Points: 
  • After the birth of her daughter, Gerti struggled with her mental health and recognized she needed help – so she turned to IEHP.
  • Through her connection to Katia, a behavioral health specialist on IEHP's maternal mental health team, Gerti learned she was experiencing postpartum depression and was connected to various resources, including supportive therapy.
  • IEHP's maternal mental health team is a small, but mighty unit within the behavioral health department that connects Members with mental health services such as therapy and psychiatry.
  • For a mental health emergency, please call the Mental Health and Suicide Crisis Hotline at 988.

HARD ROCK SUPERSTAR, IVAN MOODY, LEAD SINGER OF FIVE FINGER DEATH PUNCH, ANNOUNCES LAUNCH OF NEW CANNABIS FLOWER AND EDIBLES LINE, GREENINGS

Retrieved on: 
Monday, November 28, 2022
THC, Partnership, Mood Swings, Cannabis, Medicinals, Moody, Palms Casino Resort, CBD, Five Finger Death Punch, Hotel, Drug, Green rush

"I wanted something natural that wouldn't leave me poisoned with sluggish side effects that countered my life on the road.

Key Points: 
  • "I wanted something natural that wouldn't leave me poisoned with sluggish side effects that countered my life on the road.
  • Greenings' gummies are available in Strawberry, Dragon Fruit Punch, and Sour Blood Orange, and feature 10 milligrams of THC per serving.
  • "His cannabis line brings with it an edge that fans of Ivan and the band can totally relate to."
  • Greenings by Moody's Medicinals was created by Ivan Moody, lead singer of famed rock band, Five Finger Death Punch.

Menopause Myth-Busting Survey Reveals Sex Drive Does Not Die

Retrieved on: 
Tuesday, October 18, 2022
Education, Fear, Suppository, Woman, FUN, Sleep, LOS, Sex, Mood Swings, Probiotic, Personal lubricant, Industry, Irritability, Menopause, Libido, CEO, Lubricant, Atrophy, Birth control, Toy

LOS ANGELES, Oct. 18, 2022 /PRNewswire/ -- Ethical sex toy brand FUN FACTORY and vulvovaginal wellness brand Momotaro Apotheca have joined forces to bust the negative stereotypes about menopausal women and their sex lives for World Menopause Day.

Key Points: 
  • 1.3 million women enter menopause each year and many fear it will harm their sex lives.
  • To counter this misunderstanding, the brands conducted a survey with 1,000 U.S. women aged 40+ to understand what really happens to women's sex lives before, during, and after menopause.
  • Their curated line of sex toys, salves, and balmsincluding the new STRONIC PETITE self-thrusting toyhelp women have the sex life they deserve in midlife and beyond.
  • It also revealed that those who regularly have orgasms experience an improvement in mood swings, vaginal dryness, and sleep problems, which are the most common symptoms of menopause women say impact their sex lives.

New Study from Evernow Is Largest to Date to Show Racial and Ethnic Differences in the Experience of Menopause Symptoms

Retrieved on: 
Monday, October 17, 2022
SAN, North American Menopause Society, NCMP, Woman, Science, Menopause, MBA, Research, MPH, Multimedia, Knowledge, Mood Swings, Personal lubricant, Health, Doctor of Philosophy, CEO, Mixed anxiety–depressive disorder, NAMS, Flash, Nightclub, Pharmaceutical industry, Birth control, MD

Key findings include the following:

Key Points: 
  • Key findings include the following:
    Black women were more likely to experience hot flashes, night sweats, vaginal dryness and mood swings.
  • Hispanic women were more likely to report vaginal dryness, mood swings, and anxiety/depression.
  • East Asian women were less likely to report vaginal dryness, mood swings, and heart discomfort.
  • To build a new way of delivering healthcare based on science, innovation, and women's lived experience with menopause.

Evofem Biosciences Announces Approval of Phexxi in Nigeria

Retrieved on: 
Thursday, October 6, 2022
SAN, Reproductive health, SEC, National Agency for Food and Drug Administration and Control, Population, Woman, Infection, Annual report, Control, Citric acid, Depression, Chlamydia, Private Securities Litigation Reform Act, Lactic acid, Food, Sex, Mood Swings, Company, Irritability, Securities Exchange Act of 1934, Gonorrhea, FDA, OTCQB, Birth control, Kerosene

SAN DIEGO, Oct. 6, 2022 /PRNewswire/ -- Evofem Biosciences, Inc., (OTCQB: EVFM) today announced that its hormone-free contraceptive vaginal gel has been approved by the Nigerian Regulatory Agency NAFDAC (National Agency for Food and Drug Administration and Control). 

Key Points: 
  • Nigeria is the most populous country in Africa and the seventh largest country in the world, with 45 million women of reproductive age.
  • "We expect Nigeria will be one of many commercial markets around the world in which Evofem can generate shareholder returns while favorably impacting the lives of women," said Jenny Yip, Managing Partner at Adjuvant Capital and a Director of Evofem Biosciences.
  • Evofem is grateful to DKT Nigeria, its distribution partner in Nigeria, for their support of this registration.
  • Evofem Biosciences, Inc. is developing and commercializing innovative products to address unmet needs in women's sexual and reproductive health.

Alcohol Use Disorder Market to Witness Positive Growth at a CAGR of 8.8% by 2032 | DelveInsight

Retrieved on: 
Wednesday, September 28, 2022
Memantine, New, Social stigma, GHB, Perspiration, Compliance, ASP, Topiramate, Lists of diseases, Patient, Disulfiram, United Kingdom, Benzodiazepine, Astellas Pharma, National Institute, AUD, Psychiatric and mental health nursing, Prevalence, GABAB, Knowledge, Biomarker, Growth, Acamprosate, Alcoholism, Attention, Otsuka Pharmaceutical, Diagnostic and Statistical Manual of Mental Disorders, Drinking, ALKS, Health care, SMO, Gabapentin, Seizure, Corcept Therapeutics, Diagnosis, Hope, Population, Baclofen, Sodium oxybate, DSM, CORT, DSM-IV, LAS, VIVITROL, Mood Swings, National Institute on Alcohol Abuse and Alcoholism, Aripiprazole, Therapy, ALKS 3831, US FDA, DSM-V, Varenicline, Novo Nordisk, Pharmaceutical industry, Lithium, Alkermes, Ondansetron

LAS VEGAS, Sept. 28, 2022 /PRNewswire/ --DelveInsight's Alcohol Use Disorder Market Insights report includes a comprehensive understanding of current treatment practices, alcohol use disorder emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), Japan].

Key Points: 
  • Leading alcohol use disordercompanies such as Alkermes, Lundbeck, Otsuka Pharmaceuticals, Adial Pharmaceuticals, MediciNova, Corcept Therapeutics, Astellas Pharma, Bioprojet, and others are developing novel alcohol use disorder drugs that can be available in the alcohol use disorder market in the upcoming years.
  • DelveInsight estimates that there were approximately 25 million 12-month diagnosed prevalent cases of alcohol use disorder in the 7MM in 2021.
  • TOPAMAX (topiramate) is even recommended for alcohol use disorder treatment by the National Institute on Alcohol Abuse and Alcoholism.
  • Moreover, because of the change in alcohol use disorder diagnostic criteria from DSM-IV to DSM-V, country-specific epidemiologic data on diagnosis, severity, and treatment are scarce and thus limiting the alcohol use disorder market growth.

Rethinking "The Change": Discover 40+ Ways to Embrace Menopause

Retrieved on: 
Wednesday, September 7, 2022
Fatigue, Menopause, Science, Flash, Ageing, Human, Habit, Mood Swings, Libido, Weight gain, Fear, Medicine, Intention, News, Founder, Woman, Alternative medicine, Nutritionist, Life, Sleep, Medical device

CARLSBAD, Calif., Sept. 7, 2022 /PRNewswire/ -- Join DrTalks.com with the creator of RED Hot Sexy Meno(pause), Dr. Sharon Stills, from Tuesday, September 20th through Tuesday, September 27th to learn how to have a sexy, happy, low-stress menopause. Featured guests include Dr. Keesha Ewers (Best-Selling author and Integrative Medicine expert), Dr. Anna Cabeca (Triple Board-Certified OBGYN and Author), and Dr. Heather Sandison, ND (Founder of Marama). Each expert will be interviewed directly by Dr. Sharon Stills.

Key Points: 
  • DrTalks.com has partnered with Dr. Sharon Stills and 40+ experts to unlock the secrets of a sexy menopause at a 7-day virtual summit.
  • CARLSBAD, Calif., Sept. 7, 2022 /PRNewswire/ -- Join DrTalks.com with the creator of RED Hot Sexy Meno(pause), Dr. Sharon Stills, from Tuesday, September 20th through Tuesday, September 27th to learn how to have a sexy, happy, low-stress menopause.
  • Attendees will discover 40+ ways to embrace menopause as a time of transition and will leave the summit feeling empowered to craft the second half of their story with intention.
  • She is the founder of the RED Hot Sexy Meno(pause) Program and the host of The Science of Self Healing podcast.